Triple Combination
Showing 9976 - 10000 of >10,000
Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)
Completed
- Sickle Cell Disease
- Beta Thalassemia-Major
- alemtuzumab (Campath IH)
- +6 more
-
New Hyde Park, New YorkCohen Children's Medical Center of New York
Jul 30, 2021
Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)
Terminated
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 1, 2021
HIV-1 Trial in Spain, United States (D/C/F/TAF FDC )
Completed
- HIV-1
- D/C/F/TAF FDC placebo
-
Phoenix, Arizona
- +7 more
Jul 1, 2021
Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)
Active, not recruiting
- Non-Small-Cell Lung Carcinoma
- Pembrolizumab 200 mg
- +7 more
- (no location specified)
Aug 16, 2022
Advanced Solid Tumours, Small Cell Lung Cancer Trial in Australia, Korea, Republic of, Taiwan (IMP4297)
Recruiting
- Advanced Solid Tumours
- Small Cell Lung Cancer
-
Albury, New South Wales, Australia
- +12 more
Aug 10, 2021
Metastatic Colorectal Cancer (mCRC) Trial in Guangzhou (SHR-1701? BP102 ?XELOX, ? BP102? XELOX)
Recruiting
- Metastatic Colorectal Cancer (mCRC)
- SHR-1701、 BP102 、XELOX
- placebo、 BP102、 XELOX
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 7, 2021
HIV/AIDS Trial in Masaka (Youth Development Accounts (YDA), YDA + Multiple Family Groups (MFG))
Completed
- HIV/AIDS
- Youth Development Accounts (YDA)
- YDA + Multiple Family Groups (MFG)
-
Masaka, Uganda
- +1 more
May 2, 2022
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7
Completed
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7
- +8 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2022
Pediatric ALL Trial in Worldwide (Methylprednisolone, Prednisolone)
Recruiting
- Paediatric Stroke
-
Randwick, New South Wales, Australia
- +26 more
Jan 13, 2023
Non-Hodgkin's Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Japan (SyB L-0501, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- +3 more
- SyB L-0501
- Rituximab
-
Nagoya-city, Aichi, Japan
- +3 more
Jul 1, 2021
Acute Stroke Trial in Taichung, Taipei City (UMSC01)
Recruiting
- Acute Stroke
- UMSC01
-
Taichung, Non-US, Taiwan
- +1 more
Mar 21, 2022
Myelofibrosis (MF) Trial in Korea, Republic of, South Africa, United States (Mivebresib, Navitoclax, Ruxolitinib)
Active, not recruiting
- Myelofibrosis (MF)
- Mivebresib
- +2 more
-
Stony Brook, New York
- +6 more
Mar 23, 2022
Multiple Sclerosis, Fatigue, Exercise Therapy Trial in Stockholm (High-intensity resistance training, Low frequency of
Completed
- Multiple Sclerosis
- +4 more
- High-intensity resistance training
- Low frequency of high-intensity resistance training
-
Stockholm, SwedenAcademic Specialist Center, , Stockholm Health Services, Region
Aug 15, 2022
Stomach Cancer Trial in Beijing (KN026/Placbo Injection, Paclitaxel Injection, Docetaxel Injection)
Recruiting
- Stomach Cancer
- KN026/Placbo Injection
- +3 more
-
Beijing, ChinaChinese PLA General Hospital
Jun 16, 2022
Left Atrial Appendage Occlusion Trial in Barcelona (Apixaban vs. DAPT)
Completed
- Left Atrial Appendage Occlusion
- Apixaban vs. DAPT
-
Barcelona, SpainHospital Clinic Barcelona
Nov 21, 2022
Bridging Gaps in Neuroimaging Puzzle: New Ways to Image Brain
Recruiting
- Healthy
- +3 more
- Simultaneous EEG-fMRI at 7 Tesla
- Structural MRI at 7 Tesla
-
Bern, SwitzerlandTIC - Translational Imaging Center
Mar 3, 2023
Stroke Trial in Taipei city (Bihemispheric transcranial direct current stimulation)
Recruiting
- Stroke
- Bihemispheric transcranial direct current stimulation
-
Taipei city, TaiwanTaipei Veterans General Hospital
Nov 23, 2021
Cerebral Palsy, Infant Development, Cognitive Dysfunction Trial in Kahramanmaras (measurements)
Completed
- Cerebral Palsy
- +8 more
- measurements
-
Kahramanmaras, Dulkadiroglu, TurkeyHatice Adıgüzel
Jan 19, 2022
Severe Pneumonia Trial in Changzhou, Nanjing, Suzhou (SSBD(PCR-CRISPR/Cas12a))
Not yet recruiting
- Severe Pneumonia
- SSBD(PCR-CRISPR/Cas12a)
-
Changzhou, Jiangsu, China
- +4 more
May 8, 2022
Cystic Fibrosis Trial in United States (Tezacaftor/Ivacaftor, Ivacaftor, Tezacaftor/Ivacaftor matching )
Crohn Disease, IBD Trial in Netherlands (Adalimumab, standard step-up care)
Recruiting
- Crohn Disease
- Inflammatory Bowel Diseases
- Adalimumab
- standard step-up care
-
Maastricht, Netherlands
- +4 more
May 18, 2021